|1.||Zhao, Xiao-qin: 1 article (07/2012)|
|2.||Chen, Xing-gui: 1 article (07/2012)|
|3.||Singh, Satyakam: 1 article (07/2012)|
|4.||Liu, Zhen-guo: 1 article (07/2012)|
|5.||Chen, Li-kun: 1 article (07/2012)|
|6.||Xie, Jing-dun: 1 article (07/2012)|
|7.||Cheng, Chao: 1 article (07/2012)|
|8.||Liang, Yong-ju: 1 article (07/2012)|
|9.||Chen, Jun-jiang: 1 article (07/2012)|
|10.||Wang, Fang: 1 article (07/2012)|
07/02/2012 - "In conclusion, CCT129202 significantly reversed ABCB1- and ABCG2-mediated MDR in vitro, in vivo and ex vivo by inhibiting the function of their transporters and enhanced the eradication of cancer stem-like cells by chemotherapeutic agents. "
07/02/2012 - "Interestingly, CCT129202 also potentiated the sensitivity of cancer stem-like cells to doxorubicin. "
07/02/2012 - "Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202."
12/01/2007 - "CCT129202 causes the accumulation of human tumor cells with >or=4N DNA content, leading to apoptosis. "
07/02/2012 - "Here, we investigated the enhanced effect of CCT129202 on the cytotoxicity of chemotherapeutic drugs in multidrug resistant (MDR) cells with overexpression of ATP-binding cassette (ABC) transporters and cancer stem-like cells. "
|2.||Esophageal Neoplasms (Esophageal Cancer)
|1.||ATP-Binding Cassette Transporters (ABC Transporters)
|5.||DNA (Deoxyribonucleic Acid)
|6.||Adenosine Triphosphate (ATP)
|7.||aurora kinase (aurora A kinase)
|1.||Heterologous Transplantation (Xenotransplantation)